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Salmonella enterica, which consists of zoonotic, rod-shaped, Gram-negative bacteria, is 
the cause of about 78 million cases of foodborne illness each year and is the leading cause of 
death by bacterial foodborne illnesses in the world.  The category of foodborne illnesses itself is 
responsible for about $152 billion of annual economic losses.  When Salmonella enterica serovar 
Typhimurium infects its host, the CsrA and BarA-SirA system regulates the expression of 
metabolic and virulence genes.  Our goal is to determine the activity of the CsrA and BarA-SirA 
system during infection and how this activity coordinates carbon metabolism and the expression 
of virulence genes.  We hypothesize that CsrA activity is low during intestinal infection and high 
during systemic infection.  To test this hypothesis, genes of interest were cloned into 
translational fusion vectors containing a mCherry fluorescent reporter.  These vectors were 
inserted at flippase recognition target (FRT) sites in the Salmonella chromosome of wild type, 
sirA mutant, and csrA mutant strains.  During growth in the presence or absence of glucose and 
under conditions that induce Salmonella Pathogenicity Islands 1 and 2, these strains were 
assayed in vitro to replicate the intestinal and systemic environments in which these 
pathogenicity islands are expressed so that in the future, the results can be further analyzed in 
vivo.  Preliminary findings show that CsrA activity is present in vitro based on the regulation of 
the genes of interest by CsrA.  The outcomes of this study will not only enhance our 
understanding of the interaction between host and pathogen, but they will also be a stepping 





Chapter 1 – Introduction 
1.1 – Infection and Virulence 
 Salmonella enterica serovar Typhimurium is a rod-shaped, Gram-negative bacterium that 
possesses flagella and is facultatively anaerobic.
10
  S. Typhimurium infects the gastrointestinal 
(GI) tract which can be detrimental to infants and the immunocompromised because it can lead 
to dehydration or systemic infection.
10
  As seen in Figure 1, among foodborne illnesses, non-
typhoidal Salmonella is responsible for the highest number of Disability Adjusted Life Years 
(DALYs) in the world.
15
  Every year, approximately 78 million people worldwide contract 
Salmonella, and in the U.S. alone about 19,000 people are hospitalized and 380 people die from 
salmonellosis.
15, 22
  The category of foodborne illnesses itself is the cause for around $152 billion 
of annual economic losses.
9
  Symptoms of salmonellosis include nausea, vomiting, diarrhea, 
fever, and abdominal cramps that can last two to seven days.
10
 
 S. Typhimurium typically enters the body through the consumption of contaminated food, 
and because Salmonella is zoonotic, a major source of this contaminated food is derived from 
animals like chickens, turkeys, pigs, and cows.
3
  Shown in Figure 2, after ingestion of the 
bacteria, Salmonella enter the intestine where they invade the epithelial cells and stimulate 
macropinocytosis, or the uptake of molecules via vesicles by a cell.
11
  The bacteria multiply 
intracellularly in the epithelial cells of the intestinal mucosa.
10
  The invasion of the epithelial 
cells causes the host cells to release pro-inflammatory cytokines which induce an acute 
inflammatory response, resulting in the symptoms of salmonellosis.
10
 
 To cross the intestinal epithelium, Salmonella enter through M cells in the follicle-




surrounding the Peyer’s patches, which are a collection of lymphoid follicles.
4
  The type 3 
secretion system 1 (T3SS-1), encoded in the Salmonella pathogenicity island 1 (SPI-1), is used to 
induce pinocytosis of the bacteria by the epithelial cells.
4
  The T3SS-1 is similar to a syringe in 
the sense that it injects effectors into the epithelial cells which allow for the uptake of the 
bacteria, thus making SPI-1 important in the invasion by Salmonella into the host cells.
13, 20
  
Because SPI-1 is involved in the interaction between the bacteria and mucosal surfaces, its 
virulence gene expression is activated by low oxygen and high osmolarity, and it plays a role in 
inflammation and onset of salmonellosis symptoms like diarrhea.
13 
 After crossing the intestinal epithelium, immune cells like macrophages phagocytose the 
Salmonella.
4
  Once in the macrophage phagosome, low phosphate, low Mg
2+
, and acidic 
conditions stimulate the expression of the TTSS-2 genes, encoded by SPI-2.
8, 12
  The proteins 
released by the TTSS-2 prevent the phagosome from maturing by disrupting vesicular 
trafficking, which in turn prevents the destruction of S. Typhimurium from reactive oxygen 
species (ROS).
13
  This allows for intracellular survival of the bacteria and their proliferation.
12
  
By surviving in the macrophages, Salmonella can be transported to other areas of the body, 
leading to systemic infection.
13 
1.2 – The CsrA and BarA-SirA System and Regulation 
 The Salmonella pathogenicity islands are regulated by the carbon storage regulator 
(CsrA) and BarA-SirA system.
1
  Through the regulation of carbon metabolism, the system can 
also regulate virulence genes, motility, and biofilm formation.
1 
 CsrA is a homodimeric protein that regulates genes post-transcriptionally by binding to 
the transcribed mRNA of a gene.
1






  As an activator, CsrA stabilizes the mRNA, thus protecting the 
transcript and increasing its translation.
17
  CsrA represses translation by binding to a site that 




 CsrA activates glycolysis, metabolism of acetate, and formation of flagella but represses 
gluconeogenesis, biofilm formation, and the expression of SPI-1 and SPI-2 genes.
1, 18
  The Csr 
system incorporates the small noncoding regulatory RNAs (sRNAs), CsrB and CsrC, which have 
CsrA binding sites that allow them to sequester the CsrA protein.
1
  This prevents CsrA from 
binding to its target mRNA and decreases the amount of free CsrA present since an 
overabundance of CsrA protein present can inhibit SPI-1 genes.
1, 16
  Via the activation of 
glycolysis, which leads to the production of short chain fatty acids like acetate, the BarA-SirA 
system is activated.
16
  This in turn activates genes involved in Salmonella virulence and also 
csrB.
16
  Consequently, the combination of CsrA and the BarA-SirA system allows CsrA to 
regulate itself through the expression of csrB and csrC when activated by SirA.
12 
 During systemic infection as opposed to infection concentrated in the intestine, 
Salmonella replicates within vacuoles of macrophages.
3
  Glucose is transported into Salmonella 
by the phosphotransferase system (PTS).
3
  It has been shown that the irreversible step of 
glycolysis catalyzed by phosphofructokinase is important for intracellular replication in 
macrophages, making glycolysis necessary for this intracellular replication and glucose a critical 
carbon source for growth in macrophages and successful systemic infection.
3 
 BarA-SirA makes up a two-component regulatory system with BarA as the sensor kinase 






  BarA is membrane-bound and after sensing certain environmental signals such as 
the greater presence of metabolic products like acetate rather than propionate and butyrate, it 
phosphorylates SirA in the cytoplasm.
8, 16
  Seen in Figure 3, SirA activates csrB, which is 
involved in the repression of csrA, and indirectly activates hilA which is important for activation 
of promoters of the SPI-1 genes and the T3SS-1.
23
  The occurrence of glycolysis and the 
presence of its products in the distal ileum of the small intestine allow for the activity of 
Salmonella.
16 
1.3 – ssaJ: The Selected Target Promoter 
 The promoter of the virulence gene ssaJ was chosen as a target to study regulation by 
CsrA.  ssaJ, which is at the 5’ end of an operon, encodes a structural component of the T3SS-2, 
making it important for intracellular survival.
8, 14
  As a SPI-2 promoter, it is positively regulated 
by SsrB (Figure 3) and is activated in acidic conditions representative of the phagosome.
8
  ssrB 
is directly regulated by HilD which is positively controlled by SirA and negatively controlled by 
CsrA.
18





1.4 – Objectives 
 The goal of this study was to determine the activity of the CsrA and BarA-SirA system 
during infection and how this activity coordinates carbon metabolism with the expression of 
virulence genes. It is hypothesized that CsrA activity is low during intestinal infection and high 















Figure 1: 2010 data from the World Health Organization showing global foodborne 
Disability Adjusted Life Years (DALYs) from lowest to highest for a variety of 
pathogens.  Non-typhoidal Salmonella, which encompasses S. enterica, is shown to 
















Figure 2: The bacteria can be translocated by the epithelial cells of the host and taken 
up by macrophages afterwards.  Once in the macrophages, the bacteria can survive 
within the vesicles which may lead to local and systemic infection, or they can cause 
apoptosis of the macrophages, thus releasing the bacteria.  Salmonella may also be 











Figure 3: The CsrA and BarA-SirA regulation 
system.  The BarA-SirA system activates 
csrB/C which repress csrA.  CsrA represses 
hilD which down-regulates the global 
repressor H-NS.  H-NS represses the genes 





Chapter 2 – Materials and Methods 
2.1 – Bacterial Growth 
 Unless otherwise stated, all bacteria cultures were grown overnight in Luria-Bertani broth 
(LB) + 50 µg/mL kanamycin (kan) using the 37°C roller drum.  Colonies were grown on LB 
agar plates + 50 µg/mL kan and incubated overnight at 37°C.  The wild type Salmonella strain 
14028 was grown on LB agar without kan and incubated overnight at 37°C for further use. 
2.2 – Cloning of ssaJ 
 The promoter of interest, ssaJ, was PCR amplified using Phusion polymerase (New 
England Biolabs), and TOPO TA cloning (Invitrogen) was used to clone the fragments into pCR 
2.1 TOPO vectors that were chemically transformed into competent One Shot TOP10 
Escherichia coli DH5- cells (Invitrogen).  The transformants were plated on LB agar plates 
with kan and 10 mg/mL X-gal added.  White colonies with the lacZ gene interrupted were 
selected for plasmid purification using the Qiagen Miniprep kit.  The presence of the ssaJ 
fragment in the plasmid was confirmed by restriction enzyme digestion using the enzymes EcoRI 
and NcoI, and the DNA sequence was verified at The Ohio State University’s Plant-Microbe 
Genomics Facility (PMGF). 
2.3 – Construction of the Base Plasmid pASD1106 
 As seen in Figure 4A, the gene for mCherry in the pUC57 plasmid was PCR amplified 
using Clontech CloneAmp HiFi PCR Premix.  Primers with a multiple cloning site (MCS) at the 
end were added.  The amplified mCherry insert had fifteen extra base pairs at the ends that were 




Cloning kit, the mCherry insert was fused with the pCE70 vector at the homologous ends to 
create the final base plasmid pASD1106 (Figure 4B) that was transformed into One Shot PIR1 
competent E. coli cells (Invitrogen). 
2.4 – Control Promoters 
Four control promoters were synthesized and cloned into pUC57 by GeneScript.  These 
control promoters were used to observe regulation by CsrA.  λPR was the constitutive 
background control for mCherry expression while λPRpgaAΔrut, λPRpgaAΔrutΔcsrABS-1, and 
λPRpgaAΔrutΔcsrABS-2 were used to study the CsrA regulation of the pgaA leader.  Because the 
Rho utilization site (rut) was deleted, Rho was unable to bind and terminate transcription which 
negated Rho as a confounding variable and allowed for the ability to observe regulation by CsrA 
specifically. λPRpgaAΔrutΔcsrABS-1 contained point mutations from GG to CC in the CsrA 
binding site, and λPRpgaAΔrutΔcsrABS-2 had substitutions in the S-D and translation initiation 
sequences of csrA. 
2.5 – Translational Fusions 
 The minipreps of ssaJ, the control promoters, and pASD1106 were digested with EcoRI 
and NcoI.  The linearized fragments were gel purified using a Qiagen Gel Extraction kit and 
ligated together to form the final plasmid containing the promoter fused with mCherry at the 
multiple cloning site (MCS) in pASD1106.  The ligations were transformed into E. coli 
BW20767 competent cells that require pir for propagation of the plasmid.  The plasmids were 





2.6 – Electroporation into Salmonella 
The plasmids containing their respective promoter were electroporated into three 
different Salmonella strains with pCP20—wild type (ASD1214), sirA mutant (ASD150), and 
csrA52 mutant (ASD151)—in order to integrate the promoter and mCherry reporter onto the 
Salmonella chromosome at the flippase recognition target (FRT) site.  Figure 5 displays the 
mechanism of the electoporations.  The three strains were grown in LB broth + 200 µg/mL 
ampicillin (amp) for a maximum of eighteen hours at 30°C while shaking.  The electroporation 
had a one hour outgrowth at 37°C while shaking before being plated on LB + kan and incubated 
overnight at 42°C.  Each strain was verified by PCR amplification using the forward primer 
downstream of the pagC region in Salmonella and the reverse primer of mCherry.  
2.7 – in vitro Assays 
 ssaJ and the control promoters in their respective Salmonella strains and Salmonella 
14028, as the control, were assayed in vitro in four conditions: LB broth + 50 mM MOPS buffer 
(intestinal conditions), LB broth + 50 mM MOPS buffer + 5 mM D-glucose (systemic 
conditions), LB + 1% NaCl (SPI-1 inducing conditions), and mLPM (low phosphate, low 
magnesium-containing minimal medium and SPI-2 inducing conditions).  Liquid overnight 
cultures were started for all sixteen strains in each of the four conditions and grown for a 
maximum of eighteen hours in the 37°C roller drum.  The cultures were started from isolated 
colonies when grown in intestinal, systemic, and SPI-1 conditions but from the primary streak 
when grown in SPI-2 conditions. 
 The following day, the sixty-four liquid cultures were aliquoted into opaque, white 96-




three times to allow for three technical triplicates.  The white plates were read from the top using 
the Tecan SpectraFluor Plus microplate reader (PMGF).  mCherry was excited at a wavelength 
of 590 nm, and the emission of mCherry was measured at a wavelength of 635 nm.  Each culture 
was then aliquoted into the clear 96-well plates, and the SpectraMax M5 spectrophotometer, set 
at an absorbance of 600 nm, and SoftMax Pro software were used to determine the optical 
density (OD). 
 The in vitro assays were repeated two more times for a total of three biological replicates 
and nine technical replicates.  Data was analyzed using Prism software.  The fluorescence 
measurements of the 14028 strain grown in each type of medium were subtracted from the 
respective measurements of ssaJ and the control promoters to account for fluorescence by the 
Salmonella and medium itself.  After calculating the mean fluorescence of each strain in the 






2.8 – Tables and Figures 
 
Salmonella Strain Genotype Description 
14028 
Wild type Salmonella enterica 
serovar Typhimurium 
American Type Culture Collection 
ASD1214 
14028 ΔIG(pagC-
STM14_1502)::FRT + pCP20 
14028 with a FRT site inserted downstream of 





STM14_1502)::FRT + pCP20 
14028 sirA4::hygromycin with a pagC::cam 
insertion electroporated with pCP20 
ASD151 
14028 csrA52 ΔIG(pagC-
STM14_1502)::FRT + pCP20 
14028 with cam marker flipped out of 
csrA52::cam so csrA is unmarked; pagC::cam 




mCherry with the lambda right promoter was 
electroporated into ASD1214; Kan
R
; PCR-





mCherry with the lambda right promoter was 
electroporated into ASD150; Kan
R
; PCR-




mCherry with the lambda right promoter was 
electroporated into ASD151; Kan
R
; PCR-




mCherry with the lambda right promoter and 
pgaA leader was electroporated into ASD1214; 
Kan
R






mCherry with the lambda right promoter and 
pgaA leader was electroporated into ASD150; 
Kan
R





mCherry with the lambda right promoter and 
pgaA leader was electroporated into ASD151; 
Kan
R





ASD1214 was electroporated with mCherry 
containing the pgaA promoter and mutations in 
the CsrA binding site; Kan
R
; PCR-verified 





ASD150 was electroporated with mCherry 
containing the pgaA promoter and mutations in 
the CsrA binding site; Kan
R
; PCR-verified 
insertion at pagC insertion site. 
 








ASD151 was electroporated with mCherry 
containing the pgaA promoter and mutations 
in the CsrA binding site; Kan
R
; PCR-verified 




ASD1214 was electroporated with mCherry 
containing the pgaA promoter and mutations 
in the S-D and translation initiation 
sequences; Kan
R
; PCR-verified insertion at 





ASD150 was electroporated with mCherry 
containing the pgaA promoter and mutations 
in the S-D and translation initiation 
sequences; Kan
R
; PCR-verified insertion at 




ASD151 was electroporated with mCherry 
containing the pgaA promoter and mutations 
in the S-D and translation initiation 
sequences; Kan
R
; PCR-verified insertion at 




ASD1214 electroporated with mCherry 
containing the ssaJ promoter; Kan
R
; PCR-





ASD150 electroporated with mCherry 
containing the ssaJ promoter; Kan
R
; PCR-




ASD151 electroporated with mCherry 
containing the ssaJ promoter; Kan
R
; PCR-
verified insertion at the pagC insertion site. 





FRT orientation A 
mCherry replaced tnpR, lacZ and lacY; FRT 
sequence intact; MCS for translational fusion 
using NcoI and EcoRI; terminator between the 




pASD7000 pUC57 λPR 
λ right promoter (PR) with the leader and ATG 
of the cro gene from λ phage. 
pASD7001 pUC57 λPR-pgaAΔrut 
λ right promoter without leader fused to the 
pgaA leader with three codons of pgaA; rut 
sites are deleted to remove Rho-dependent 
regulation. 
pASD7002 pUC57 λPR-pgaAΔrutΔcsrABS-1 
λ right promoter without the leader fused to 
the pgaA leader with three codons of pgaA; rut 
sites are deleted; the CsrA binding sites are 






Plasmid Genotype Description 
pASD7003 pUC57 λPR-pgaAΔrutΔcsrABS-2 
λ right promoter without the leader fused to 
the pgaA leader with three codons of pgaA; rut 
sites are deleted; the csrA S-D and translation 
initiation sequences contain substitution 
mutations. 
pSLZ100 λPR-mCherry 
mCherry in pASD1106 with lambda PR 





mCherry in pASD1106 with pgaA promoter 





mCherry in pASD1106 with the pgaA 
promoter; rut sites were deleted; CsrA binding 
sites mutated (GG to CC); cloned into EcoRI 




mCherry in pASD1106 with the pgaA 
promoter; rut sites were deleted; csrA S-D and 
translation initiation sequences mutated; 




pSLZ105 pASD1106 ssaJ  
mCherry in pASD1106 with the ssaJ 




pSLZ118 pCR 2.1 TOPO PssaJ  
PCR-amplified promoter region of ssaJ; 
EcoRI and NcoI sites for translational fusion 







contains wild-type tnpR Shine-
Dalgarno; FRT orientation A 
Inverse PCR-amplified product was fused 


















Primer Sequence (5’ – 3’) Description 
BA3137 TTGAATTCGCCATCGCGGATGTCGCCTGTCTTATCTACC 
Forward primer of the 
ssaJ insertion fragment 
for translational fusion 
to a fluorescent reporter 




Reverse primer of the 
ssaJ insertion fragment 
for translational fusion 
to a fluorescent reporter 




Forward primer to 
inverse PCR-amplify 
pCE70 for making the 
csrA translation vector. 
BA3200 TCTAGAAAGTATAGGAACTTCCCGATCCCAAGC 
Reverse primer to 
inverse PCR-amplify 
pCE70 for making the 




Forward primer to PCR 
amplify mCherry with 
the FRT terminator and 
MCS for HD In-Fusion 
cloning with inverse 
PCR-amplified pCE70. 
BA405 GCAATGTAACATCAGAGATTTTGAG 
Forward primer of the 
mCherry reporter. 
BA3202 GCTTAAATCGCATGCTTATTTATACAGTTCGTCCATA 
Reverse primer to PCR 
amplify mCherry for 
HD In-Fusion cloning 
with the inverse PCR-
amplified pCE70. 
BA1554 CGGCACGGTAAAGGCGACATTTAAA 
Primer for the 
confirmation of the 
knock in downstream 
of pagC in Salmonella 
 
 












Figure 4A: Construction of the pASD1106 base plasmid using Clontech In-Fusion HD Cloning. 
Figure 4B: Map of the final pASD1106 
base plasmid which was used to create 
translational fusions with the mCherry 
reporter after the promoters were cloned 













Table 3: Promoters for the genes of interest and their progress of being cloned into pASD1106.  











Figure 5: Recombination of the plasmids onto the Salmonella chromosome at the flippase 
recognition target (FRT) site. The vectors containing the promoter and mCherry reporter 
were electroporated into Salmonella wild type, sirA mutant, and csrA52 mutant strains where 
they integrated into the chromosome at the FRT site.  The rpoC terminator prevents read-












Table 4: Control promoters and promoters for the genes of interest and their progress of 
being electroporated into the three Salmonella strains.  The strains analyzed for the purpose 




Chapter 3 – Results and Discussion 
3.1 – CsrA Regulation in the Control Promoters 
 The constitutive λPR::mCherry fusion acts as a negative control for the expression of the 
mCherry reporter to confirm non-differential expression despite being in a sirA or csrA52 mutant 
background.  This can be seen in Figures 6 through 9 based on the fact that the λPR::mCherry 
control has consistent expression of mCherry as this gene is not normally found in Salmonella 
and thus is not regulated by the CsrA and BarA-SirA system.  Consequently, the normalized 
fluorescence levels of mCherry show no statistical difference between the wild type, sirA mutant, 
and csrA52 mutant.  However, when the strains were grown in intestinal and SPI-1 inducing 
conditions (Figures 6 and 8), there is a statistically significant decrease in mCherry expression 
from the wild type to the sirA mutant which shows regulation by CsrA and SirA.  This may 
suggest that there are other gene products regulated by CsrA that are activated in these specific 
conditions that also regulate λPR. 
pgaA is a well-characterized leader, allowing for it serve as a positive control for CsrA 
regulation.  Nevertheless, a second level of regulation by Rho was found and thus serves as a 
confounding variable to CsrA regulation because as seen in Figure 10, Rho can terminate 
transcription by binding to the Rho utilization (rut) site.
2
  This may be mistaken for decreased 
activity of the promoter since its respective gene does not become translated into a functional 
protein, so as a result, the rut site was deleted to remove the confounding variable.  Because 
pgaA has been shown to be post-transcriptionally repressed by CsrA, this was used to 
demonstrate the presence of CsrA activity in vitro.
25
  Without the confounding variable rut, CsrA 




 The λPRpgaAΔrut construct should be regulated by CsrA directly and by SirA indirectly.  
To test this, the construct was grown in four conditions to see if this regulation would be 
observed.  Figures 6 through 9 show the wild type strain having the greatest expression.  
However when sirA is deleted, expression of mCherry, and hence the pgaA leader, significantly 
decreases as expected.  Because pgaA is repressed by CsrA, when sirA is deleted, CsrB is not 
produced; therefore, CsrA continues to be produced which in turn leads to reduced expression of 
pgaA.
25
  Expression of mCherry in the csrA52 mutant is not as high as expected.  It is thought 
that without CsrA activity present, expression of the pgaA leader would be greater than that of 
the wild type since pgaA would not be repressed by CsrA, but this is not observed in Figures 6 
through 9.  There is a possibility that the mutation in the csrA52 mutant may still allow for some 
of the original functionality of CsrA and repress pgaA in moderation.  In addition, trends of the 
expression levels of mCherry in the λPRpgaAΔrut construct follow a similar trend as the λPR 
construct.  This may further indicate that λPR was a poor selection as a negative control for 
mCherry expression since there is still regulation of the λPR promoter observed when there 
should not be.  The regulation of λPR by CsrA in intestinal and SPI-1 conditions introduces a 
confounding variable for the λPRpgaAΔrut construct and makes it difficult to determine if CsrA 
and SirA are regulating only pgaA.   
 The λPRpgaAΔrutΔcsrABS-1 and λPRpgaAΔrutΔcsrABS-2 constructs contain different 
mutations that eliminate CsrA regulation, either by preventing CsrA from binding or from being 
translated, and this shows pgaA expression levels when CsrA is not present.  As seen in Figures 
6 through 9, these mutations appear to have partially eliminated regulation by CsrA and SirA.  
However, this may be due to the uneven activity of the λPR promoter in the different 




 To take into account for the CsrA and SirA regulation happening in the λPR::mCherry 
fusion, the normalized relative fluorescence units of the λPRpgaAΔrut, λPRpgaAΔrutΔcsrABS-1, 
and λPRpgaAΔrutΔcsrABS-2 strains can be divided by the normalized relative fluorescent units of 
the corresponding λPR strains since each of these promoters also have λPR incorporated into the 
fusion.  That way, the excess fluorescence from the λPR::mCherry fusion can be omitted and the 
regulation of pgaA by CsrA and SirA can be observed in isolation from these confounding 
effects of λPR regulation by CsrA and SirA in addition to regulation by Rho.   
3.2 – Regulation of ssaJ by CsrA 
 As seen in Figure 11, the expression of ssaJ follows a similar trend when the strains are 
grown in intestinal, systemic, and SPI-1 inducing conditions.  The wild type and sirA mutant 
strains do not show significant differences in expression levels of ssaJ, but its expression 
increases greatly in the csrA52 mutant strain.  As a promoter that plays a role in the T3SS-2, SsaJ 
has the highest level of activity in SPI-2 inducing conditions particularly for the wild type strain.  
Like for the control promoter λPRpgaAΔrut, ssaJ expression decreases in the sirA mutant and is 
greater in the csrA52 mutant than the sirA mutant.  This suggests that CsrA represses ssaJ 
because without SirA indirectly repressing csrA, there is more CsrA and thus less ssaJ 
expression and more ssaJ expression when CsrA is not present.  This makes sense because CsrA 
represses the SPI-2 promoter ssrB that activates ssaJ.
18 
3.3 – Conclusions and Future Directions 
 Based on the in vitro assays of the control promoters and ssaJ, it can be seen that CsrA 




regulation by CsrA takes place in vivo.  The goal is to observe the activity of the control 
promoters and ssaJ in tissue culture and ultimately in a murine model. 
 Epithelial cells and mouse macrophages will be infected with the respective strains of 
Salmonella.  The multiplicity of infection (MOI) for Salmonella has yet to be determined.  The 
infection of epithelial cells will be incubated for a shorter period of time to allow for the 
expression of SPI-1 genes that permit the invasion of the epithelial cells by Salmonella.  The 
infection of the macrophages will be incubated longer so that SPI-2 genes may be expressed to 
allow for the proliferation of Salmonella, thus mimicking systemic infection. 
 After incubation, the excess Salmonella, which have yet to infect the cells, will be killed 
off using an antibiotic that does not penetrate eukaryotic cells.  To look at CsrA regulation, the 
expression of the promoters between infected and uninfected cells will be observed by 
quantifying the intensity of mCherry emission using confocal microscopy.  The parameters for 
measuring the intensity of mCherry emission will need to be defined by quantifying the emission 
of the lowest and highest fluorescing control promoters before working with ssaJ. 
 It is suspected that ssaJ activity will be the highest in the macrophage infection since it 
codes for a structural component of the T3SS-2 which allows for intracellular survival and 
proliferation of Salmonella.
12, 14
  Some regulation of ssaJ by CsrA is expected to occur during 
infection of the epithelial cells but more greatly pronounced during infection of macrophages 
considering that these immune cells can play a role in carrying Salmonella to other parts of the 
body and therefore possibly leading to systemic infection.
12
  Moreover, the activity of the BarA-
SirA system is greater in the intestines where the epithelial cells are located due to the higher 
concentration of short chain fatty acids that can activate this system.
16




BarA-SirA system, csrB is expressed resulting in lower activity of CsrA.
16
  These assumptions 
regarding infection of the epithelial cells and macrophages may also apply to the mouse model.  
Activity of CsrA and expression of ssaJ will be lower in cells of the small intestine.  However, 
regions in the mouse to where macrophages can carry Salmonella, like the mesenteric lymph 
nodes, liver, and spleen, will have greater activity of CsrA and expression of ssaJ.
4
  
 In the end, the outcomes of this study will enhance the understanding of the interaction 
between host and pathogen.  This may be a stepping stone to the development of therapeutics 












































































Figure 6: Expression from the control promoters by cells grown in intestinal conditions.  
The expression of mCherry was normalized by dividing the fluorescence by the OD for 
each respective strain.  One-way ANOVA statistical analysis was performed on this data. 









































































Figure 7: Expression from the control promoters of cells grown in systemic conditions.  
The expression of mCherry was normalized by dividing the fluorescence by the OD for 
each respective strain.  The data was analyzed using one-way ANOVA statistical 













































































Figure 8: Expression of the control promoters by cells grown in SPI-1 conditions.  The 
expression of mCherry was normalized by dividing the fluorescence by the OD for 
each respective strain.  One-way ANOVA statistical analysis was used to analyze this 










































































Figure 9: Expression of the control promoters by cells grown in SPI-2 conditions.  
The expression of mCherry was normalized by dividing the fluorescence by the OD 
for each respective strain.  The data was studied using one-way ANOVA statistical 


















Figure 10: Rho termination of the transcription of pgaA.  The binding of CsrA allows 
for Rho-dependent termination of pgaA transcription by preventing the formation of a 
hairpin loop and exposing the rut sites.  Without CsrA, the rut sites are not available 













Figure 11: Expression of the target promoter ssaJ by cells grown in intestinal, 
systemic, SPI-1, and SPI-2 conditions.  The expression of mCherry was normalized 
by dividing the fluorescence by the OD for each respective strain.  The statistical 
analysis one-way ANOVA was used to analyze the data.  p = 0.05, * ; p = 0.01, ** ; 
p = 0.001, *** ; p = 0.0001, **** 
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